Pediatric Drugs Market is segmented By Indication (Cancer (Leukemia, Brain Tumors, Lymphomas) Respiratory Diseases, Neurological Diseases, Genetic Diseases, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospitals & Clinics, Pharmacy, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Market Size in USD
CAGR12.3%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 12.3% |
Market Concentration | High |
Major Players | Novartis AG, Pfizer Inc., Sanofi, Johnson & Johnson Services, Inc., Bayer AG |
The pediatric drugs market is estimated to be valued at USD 147.8 Bn in 2024 and is expected to reach USD 333 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.3% from 2024 to 2031. The market has witnessed steady growth over the past decade attributed to the increasing number of clinical researches focusing on developing drugs exclusively meant for pediatric population.